FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. DELL
4. MDB
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. USO
10. SNOW

Go back to FDA Advisory Committee Recommends Approval of Paratek’s Omadacycline
Profile Technologies, Inc. (NASDAQ: PRTK) Delayed: 2.23 --0 (-0%)
Previous Close $2.23    52 Week High $22.00 
Open $0.00    52 Week Low $9.80 
Day High $2.23    P/E N/A 
Day Low $2.23    EPS $-0.08 
Volume 1,940,343       

(NASDAQ: ZLAB) Delayed: 26.48 +1.18 (4.66%)
Previous Close $25.30    52 Week High $ 
Open $26.00    52 Week Low $ 
Day High $27.50    P/E N/A 
Day Low $26.00    EPS $ 
Volume 1,056,846